LifePlan Financial LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 4.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,063 shares of the pharmacy operator’s stock after selling 874 shares during the quarter. LifePlan Financial LLC’s holdings in CVS Health were worth $946,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health during the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory purchased a new position in CVS Health in the third quarter worth $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health in the third quarter valued at $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the 3rd quarter worth $32,000. Finally, Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health in the 3rd quarter valued at about $33,000. 80.66% of the stock is owned by hedge funds and other institutional investors.
CVS Health Trading Up 1.5 %
Shares of CVS stock opened at $52.72 on Tuesday. The firm’s 50-day simple moving average is $51.27 and its 200-day simple moving average is $56.29. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The firm has a market cap of $66.35 billion, a P/E ratio of 13.38, a PEG ratio of 0.79 and a beta of 0.59.
CVS Health Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 5.05%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.
Analyst Ratings Changes
CVS has been the subject of a number of research reports. Piper Sandler reduced their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. Truist Financial decreased their target price on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Evercore ISI raised their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Finally, Mizuho reduced their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $68.71.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Recommended Stories
- Five stocks we like better than CVS Health
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Intuitive Surgical Leads the Pack in Robotic Surgery Innovation
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Transports Are Trending Higher: It’s a Golden Time to Buy More
- Pros And Cons Of Monthly Dividend Stocks
- A Hidden Winner in Manufacturing and Energy Set for a Breakout
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.